The immune therapy program will make cutting edge contributions to the field of immune-oncology by uncovering novel findings in basic and translational research, as well as learning from patient responses in clinical trials to improve response rates and quality of life. Our goal is also to develop novel technologies and reagents to remain at the forefront of this field.


Ohashi, Pamela (Chair)

Bray, Mark R

Brooks, David

Hirano, Naoto

Mak, Tak W

McGaha, Tracy

Nguyen, Linh

Paige, Christopher

Reedijk, Michael

Sacher, Adrian